Barclays PLC Schedule 13G passive stakes

Barclays PLC has reported a 6.47% passive beneficial ownership stake in Columbus Acquisition Corp, holding 514,499 common shares.

Barclays PLC has disclosed a 6.54% beneficial ownership stake in Churchill Capital Corp X, holding 2,730,528 units as of June 30, 2025.

Barclays PLC has disclosed a passive 6.62% beneficial ownership stake in Bridge Investment Group Holdings Inc. Class A common stock.

Barclays PLC has disclosed a beneficial ownership of 6.88% of Ironwood Pharmaceuticals Inc.'s common stock, totaling 11,133,857 shares.

Barclays PLC has reduced its beneficial ownership in GRAF Global Corp-CL A to 4.29% of common stock, as disclosed in an amended Schedule 13G filing.

Barclays PLC has filed an amended Schedule 13G, disclosing a 4.98% beneficial ownership stake in Bleichroeder Acquisition Corp.

Barclays PLC has filed an amended Schedule 13G, disclosing a 4.28% beneficial ownership stake in Lionheart Holdings CL A as of June 30, 2025.

Barclays PLC has disclosed a 4.58% beneficial ownership stake in Mountain Lake Acquisition-A, holding 1,092,500 common shares.

Barclays PLC has filed an amendment to its Schedule 13G, disclosing a 3.52% beneficial ownership stake in Plum Acquisition Corp IV as of June 30, 2025.

Barclays PLC has filed an amended Schedule 13G, disclosing a 3.00% beneficial ownership stake in Roman DBDR Acquisition Corp, totaling 690,045 common shares as of June 30, 2025.

Barclays PLC has filed an amendment to its Schedule 13G, disclosing a 4.29% beneficial ownership stake in SIM ACQUISITION CORP I-A as of June 30, 2025.

Barclays PLC has filed an amended Schedule 13G, disclosing a 3.81% beneficial ownership stake in Aldel Financial II Inc.

Barclays PLC has reported a reduced beneficial ownership stake of 4.18% in Churchill Capital Corp IX, falling below the 5% threshold.

Barclays PLC has disclosed a 4.79% beneficial ownership stake in Andretti Acquisition Corp, holding 1,138,620 common shares.

Barclays PLC has reported a beneficial ownership of 5.04% in Gesher Acquisition Corp II-A, holding 753,124 common shares.

Barclays PLC has disclosed a beneficial ownership of 5.16% in Jena Acquisition Corp II, holding 1,199,434 units.

Barclays PLC has disclosed a passive 4.05% ownership stake in Everi Holdings Inc. common stock as of June 30, 2025.

Barclays PLC has filed an amendment to its Schedule 13G, disclosing a 3.19% beneficial ownership stake in PLAYAGS INC as of June 30, 2025.

Barclays PLC has filed an amendment to its Schedule 13G, reporting zero beneficial ownership in VERASTEM INC common stock.

Barclays PLC has disclosed a passive 4.69% beneficial ownership stake in GSR III Acquisition Corp, holding 1,100,170 common shares.

Barclays PLC has filed an amended Schedule 13G, disclosing a 4.94% beneficial ownership stake in Launch Two AcquisitionCL A common stock.

Barclays PLC has filed an amended Schedule 13G, disclosing a 4.94% beneficial ownership stake in Vine Hill Capital-Class A Common Stock as of June 30, 2025.

Barclays PLC has reported a significant 7.13% beneficial ownership stake in K&F Growth Acquisition Corp., totaling over 2.1 million shares.

Barclays PLC has disclosed a significant beneficial ownership stake of 7.99% in Launch One Acquisition Corp, holding over 1.8 million common shares.

Barclays PLC has filed an amendment to its Schedule 13G, disclosing a 4.74% beneficial ownership in Silverbox Corp IV-A's common stock.

Barclays PLC has disclosed a 5.44% beneficial ownership stake in Live Oak Acquisition Corp-A, holding over 1.25 million common shares.

Barclays PLC has reported a beneficial ownership of 5.31% in Myriad Genetics Inc., totaling 4,899,951 common shares, held for ordinary business purposes.

Barclays PLC has reported a beneficial ownership of 1,177,600 common shares, representing 5.23% of Texas Ventures Acquisition-A.

Barclays PLC has filed an amended Schedule 13G, disclosing a 5.79% beneficial ownership stake in AA Mission Acquisition Corp. as of March 31, 2025.

Barclays PLC has filed a Schedule 13G, revealing a beneficial ownership of 7.18% in FACT II Acquisition Corp, held for ordinary course of business.